Trials / Unknown
UnknownNCT05088161
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- The Affiliated Hospital of Qingdao University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In this study, we will use high-throughput proteomics techniques to search for biomarkers of post-operative prognosis of pancreatic cancer in samples of patients who have been diagnosed with pancreatic cancer through bioinformatics analysis.
Detailed description
This study plan from the affiliated hospital of Qingdao university collected 20 cases of patients with pancreatic cancer pathological tissue samples and clinical data, including clinical diagnostic information, laboratory tests, imaging examination results and other information data), through high-throughput proteomic technology in pancreatic cancer pathological finding biomarkers, the bioinformatics analysis to explore the prognosis biomarkers.
Conditions
Timeline
- Start date
- 2021-05-13
- Primary completion
- 2021-11-12
- Completion
- 2022-03-12
- First posted
- 2021-10-21
- Last updated
- 2021-10-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05088161. Inclusion in this directory is not an endorsement.